INDOBORAX

Q2 FY27 Consolidated Revenue ₹58.94 Cr vs ₹57.85 Cr (▲2% YoY) EBITDA ₹4.96 Cr vs ₹19.84 Cr (▼75% YoY) PAT ₹4.75 Cr vs ₹16.26 Cr (▼71% YoY) EBITDA Margin 8.4% vs 34.3% (▼2590bps)

- Indo Borax & Chemicals Limited has updated on the creation of a pledge over 51,94,560 equity shares (approx. 14% stake) of its subsidiary, Kronox Lab Sciences Limited. - The pledge was created on November 3, 2026, as security for a term loan facility of approximately ₹225 crores availed for financing the acquisition of Kronox shares. - There is no change in shareholding or control of the company in Kronox, and it continues to remain a subsidiary.

- Indo Borax & Chemicals Limited executed an amendment agreement on October 22, 2026, to modify the original Share Purchase Agreement dated August 20, 2026, regarding Kronox Lab Sciences Limited. - The amendment deletes clauses related to the lock-in of the sellers' 9.95% shareholding and the purchaser's right of first refusal. - The changes remove residual ambiguity regarding the sellers' status as promoters or part of the promoter group.

- Indo Borax & Chemicals Limited created a pledge over 51,94,560 equity shares of its subsidiary, Kronox Lab Sciences Limited (representing 14% of Kronox's paid-up equity share capital). - The pledge is created as security for a term loan facility of ₹225 crores availed for financing the acquisition of equity shares of Kronox. - The company holds 64.26% stake in Kronox, and the pledge does not impact control or shareholding status.

- Indo Borax & Chemicals Limited has issued a Postal Ballot Notice seeking member approval via remote e-voting. - Cut-off date for voting eligibility: Friday, October 9, 2026. - Remote e-voting period: Tuesday, October 13, 2026 (9:00 A.M.) to Wednesday, November 11, 2026 (5:00 P.M.). - Special Business: Approval under Section 180(1)(a) of the Companies Act, 2013 to create security/charges on company assets for borrowings up to ₹400 Crores.

- Indo Borax & Chemicals Limited completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited on September 29, 2026. - Appointed Mr. Suresh Kalra as Managing Director and CEO and Mr. Shashikant Bharuka as CFO of Kronox Lab Sciences. - A new Board of Directors has been constituted, and key committees have been reconstituted.

- Indo Borax & Chemicals Limited has completed the acquisition of 64.26% of the total paid-up equity share capital of Kronox Lab Sciences Limited. - The acquisition involves 2,38,44,000 equity shares purchased from the sellers pursuant to the share purchase agreement dated August 20, 2026. - The transaction was successfully completed on September 29, 2026.

- Trading window for dealing in company's shares closed from October 01, 2026. - Closure will continue until 48 hours after the declaration of Q2/H1 FY27 financial results. - Date of the board meeting for results approval will be intimated separately.

- Indo Borax & Chemicals Limited has availed funding of ₹225 crore from a lending institution on September 23, 2026. - The funding is for financing the acquisition of equity shares of Kronox Lab Sciences Limited. - Disclosure made pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

- Investor Meeting Schedule - Date: September 28, 2026 - Time: 12:00 p.m. to 1:00 p.m. - Organised by: Arihant Capital - Bharat Connect Conference: Rising Stars - September 2026 - Mode: Virtual